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Early repolarization (or J wave) is a common electrocardiographic ﬁnding that occurs in 1% to 10% of
healthy persons. It has been generally considered benign for decades. However, there is increasing
evidence showing that early repolarization is associated with the susceptibility to ventricular
ﬁbrillation and sudden cardiac death. Therefore, early repolarization syndrome, or J-wave syndrome,
has recently been proposed as a new disease entity. Brugada syndrome is characterized by ST-segment
elevation in the right precordial leads (V1 to V3) of a 12-lead electrocardiogram, and is another form of
idiopathic ventricular ﬁbrillation associated with J-point elevation. Brugada syndrome and early
repolarization syndrome share genetic, clinical, and electrophysiological characteristics, such as
causative genes, male dominance, pause-dependent augmentation of J-point elevation, and response
to drugs. However, these two diseases also have certain differences. This review focuses on the
similarities and differences between Brugada syndrome and early repolarization syndrome, both of
which are associated with J-point elevation and sudden cardiac death.
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Early repolarization or J-wave is characterized by an elevation
at the junction between the end of the QRS complex and the
beginning of the ST-segment (J-point) in a 12-lead electrocardio-
gram (ECG). Early repolarization is a common electrocardio-
graphic ﬁnding that occurs in 1% to 10% of healthy persons, and
it has been generally considered benign for decades [1]. However,
early repolarization can be observed under various biological
abnormalities, such as low body temperature, hypercalcemia,
and ischemia [2–5]. Furthermore, there is increasing evidencert Rhythm Society. Published by E
: þ81 25 227 0774.
Watanabe).showing that early repolarization is associated with an increased
risk of ventricular ﬁbrillation and sudden cardiac death [6–8].
In a number of case reports, early repolarization has been
associated with the pathogenesis of idiopathic ventricular ﬁbrilla-
tion [9,10]. In 2008, Haissaguerre et al. [6] reported in a case-
control study that the early repolarization pattern is more frequent
in patients with idiopathic ventricular ﬁbrillation (31%) than in
matched controls (5%). After this report was published in the New
England Journal of Medicine, idiopathic ventricular ﬁbrillation
associated with early repolarization, the so-called early repolariza-
tion or J-wave syndrome, started receiving increasing attention.
Brugada syndrome is characterized by ST-segment elevation in
the right precordial leads (V1 to V3) of a 12-lead ECG and
episodes of ventricular ﬁbrillation [11]. Brugada syndrome is
another form of idiopathic ventricular ﬁbrillation associated with
J-point elevation, and this led Antzelevitch and Yan [12] tolsevier B.V. All rights reserved.
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available evidence about the similarities and differences between
Brugada syndrome and early repolarization syndrome.2. Clinical characteristics
Brugada syndrome is more common in Southeast Asia, including
Japan, with an estimated prevalence of 12 in 10,000 individuals,
compared with Western countries where the estimated prevalence
is 1 to 5 in 10,000 individuals. However, the incidence of early
repolarization syndrome and the regional variation in incidence are
not known [13]. In both Brugada and early repolarization syn-
dromes, the age at diagnosis is around 40 years, and 70% to 80% of
patients are men (Table 1).[14–17] A family history of unexplained
sudden death is present in 20% to 30% of patients with Brugada
syndrome and in 10% to 20% of patients with early repolarization
syndrome [14–17]. In Brugada syndrome, arrhythmia events result-
ing from ventricular ﬁbrillation mainly occur during sleep, while
resting, or after meals [18]. However, cardiac arrest occurs during
sleep in only 19% and 26% of patients with early repolarization
syndrome in the reports by Haissaguerre et al. [6] and us, [17]
respectively, and also occurs during physical exertion in 9% to 19% of
patients. The frequency of arrhythmia recurrences in survivors of
ventricular ﬁbrillation or cardiac arrest seems similar; the annual
incidence of ventricular ﬁbrillation is 7% to 8% in patients with
Brugada syndrome and 6% to 7% in those with early repolarization
syndrome [14–17]. In addition to their susceptibility to ventricular
ﬁbrillation, atrial ﬁbrillation has also been found in 10% to 20% of
patients with Brugada syndrome and in 23% of patients with early
repolarization syndrome [17,19].3. Electrophysiological characteristics
In the 12-lead ECG, Brugada syndrome is characterized by a
unique ‘‘coved-type’’ J-point and ST-segment elevation in the
right precordial leads V1 to V3, whereas early repolarization
syndrome is characterized by an elevation of the J-point, either
as QRS slurring or notching of Z0.1 mV in Z2 consecutive
inferior leads (II, III, and aVF) or lateral leads (I, aVL, V5, and
V6). However, the diagnostic criteria for early repolarization
syndrome, such as the morphology and amplitude of J-point
elevation, are still controversial [6]. However, in earlyTable 1
Clinical characteristics.
Eary repolarization
syndrome
Brugada
syndrome
Male sex 87% 76–96%
Age, years 44717 41–50
Family history of sudden death 13% 19–34%
Activity at initial cardiac arrest 26%
Sleeping 23% 82%
Rest 19%
Physical effort 32%
Other activities 48% 63–73%
Inducible ventricular ﬁbrillation 23% 19%
Atrial ﬁbrillation
Location of early repolarization/J-point
elevation
Inferior 70%
Lateral 70% Inferolateral,
8%
Right precordial 21% 100%
Multiple locations of early
repolarization
53% 
Modiﬁed from Watanabe et al. [17] and Kamakura et al. [15] with permission.repolarization syndrome, J-point elevation in the right precordial
leads can also be found in up to 20% of patients (Table 2),
[17,20] and early repolarization appearing globally in the inferior,
lateral, and right precordial leads has been associated with the
highest risk of ventricular ﬁbrillation [12,20]. Similarly, the
presence of inferolateral early repolarization is associated with
an increased risk of arrhythmia events in patients with Brugada
syndrome.
In both Brugada and early repolarization syndromes, the
characteristic electrocardiographic changes are dynamic, and the
amplitude and the existence of the characteristic J-point/ST-
segment or early repolarization varies. J-point elevation becomes
most prominent just before the development of ventricular
ﬁbrillation, supporting the arrhythmogenicity of J-point abnorm-
alities [6,11]. Both syndromes share pause- and bradycardia-
dependent augmentation of the J-point amplitude (Figure), which
has been suggested useful in distinguishing persons with an
increased risk of arrhythmia events from those with benign early
repolarization [21]. Because the electrocardiographic changes can
occasionally disappear, efforts to provoke electrocardiographic
changes have been attempted. In Brugada syndrome, sodium
channel blockers are used to detect the diagnostic Brugada
electrocardiographic pattern. However, sodium channel blockers
attenuate J-point elevation in early repolarization syndrome, and
to date, there is no established test for the diagnosis [22].
Fig. 1 Conduction abnormalities at the His–Purkinje system
and the right ventricular outﬂow tract are sometimes evident in
Brugada syndrome. In our recent report, the PR interval and QRS
duration are also longer in patients with early repolarization
syndrome than in matched controls (Table 2) [23]. Table 3 shows
a comparison of the electrocardiographic parameters between
patients with early repolarization syndrome and those with
Brugada syndrome. The incidence of late potential in signal-
averaged ECG is higher in patients with Brugada syndrome
(60%) than in those with early repolarization syndrome (7%)
[22]. The QT interval is relatively short in patients with early
repolarization syndrome [6,23]. The QT interval is unusually short
in patients with Brugada syndrome who are affected by speciﬁc
genetic defects (mutations in calcium channel genes), as
described below [24]. The early repolarization pattern is fre-
quently found and is associated with an increased risk of
arrhythmia events in patients with short QT syndrome [25].4. Genetic basis
Similar to other arrhythmia syndromes, Brugada and early
repolarization syndromes are inherited diseases that are usually
transmitted in an autosomal-dominant manner [26]. To date, 13
genes have been associated with Brugada syndrome. Loss-of-
function mutations in SCN5A, encoding the cardiac predominantTable 2
Electrocardiographic parameters in Japanese patents with early repolarization
syndrome.
ERS patients
N¼44
Matched controls
N¼220
P value
Male sex, N (%) 39 (89) 95 (89) –
Age, years 47718 47717 –
Heart rate (beats/
min)
63710 70714 o0.001
PR interval (ms) 173735 148722 o0.001
QRS interval (ms) 94716 9078 0.008
QTc (ms) 391730 397722 0.07
ERS denotes early repolarization syndrome; QTc, corrected QT interval;modiﬁed
from Watanabe et al., [23] with permission.
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Fig. 1. Electrocardiogram of a patient with Brugada syndrome. The electrocardiogram was recorded just after an episode of ventricular ﬁbrillation. Early repolarization is
present in leads I, aVL, V4, V5, and V6. Note that the amplitude of the J-point of the Brugada-type electrocardiogram and the early repolarization pattern was increased
after a pause.
Table 3
Comparisons of electrocardiographic parameters between ERS and Brugada
syndrome.
ERS patients N¼14 Brugada patients N¼12 P value
Heart rate (beats/min) 6377 6578 NS
PR interval (ms) 179734 191733 NS
QRS interval (ms) 90713 97718 NS
QTc (ms) 387723 38472 NS
Modiﬁed from Kawata et al., [22] with permission.
Table 4
Genetic basis.
Gene Frequency Function
Brugada syndrome
Naþ channel
SCN5A 10–30% INaþk
SCN1B Rare INaþk
SCN3B Rare INaþk
GPD1L Rare INaþk
MOG1 Rare INaþk
SLMAP1 Rare INaþk
Ca2þ channel
CACNA1C 5% ICa2þk
CACNB2 5% ICa2þk
CACNA2D1 Rare ICa2þk
Kþ channel
HCN4 Rare IKþm
KCNE3 Rare IKþm
KCNE5 Rare IKþm
KCND3 Rare IKþm
KCNJ8 Rare IKþm
Early repolarization syndrome
Naþ channel
SCN5A Unknown INaþk
Ca2þ channel
CACNA1C Unknown ICa2þk
CACNB2 Unknown ICa2þk
CACNA2D1 Unknown ICa2þk
Kþ channel
KCNJ8 Unknown IKþm
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account for 20% of patients with Brugada syndrome (Table 4)
[13,27]. Other genes, including SCN1B [28], SCN3B [29], GPD1L
[30], MOG1 [31], and SLMAP [32], encoding proteins that modify
the sodium channel function, are also causative genes of Brugada
syndrome. The importance of sodium channel genes in the
pathogenesis of Brugada syndrome and the similarities of early
repolarization syndrome to Brugada syndrome led us to ﬁnd
SCN5A mutations in patients with early repolarization syndrome
(Table 4) [23]. These two diseases have further common genetic
backgrounds, including calcium channel genes such as CACNA1C,
CACNB2b, and CACNA2D1, as well as KCNJ8, which encodes the
ATP-sensitive potassium channel [24,33–35]. In fact, all of the ﬁve
causative genes reported for early repolarization syndrome are
also causative genes of Brugada syndrome. In early repolarization
syndrome, an ion channel dysfunction of a pathogenic genetic
background results in either the decrease of inward currents
(Naþ and Ca2þ currents) or the increase of outward currents
(Kþ currents), both of which can cause shortening of the action
potential duration, consistent with a relatively short QT interval.5. Treatment
Implantable cardioverter deﬁbrillator is the only proven effec-
tive treatment to prevent sudden cardiac death in patients withBrugada syndrome and those with early repolarization syndrome.
The arrhythmogenicity of vagal stimulation has been reported,
and the b-adrenergic agonist isoproterenol has been found
effective for treating electrical storm in both diseases. To date,
quinidine has been the only drug to show efﬁcacy in preventing
recurrent episodes of ventricular ﬁbrillation in patients with
Brugada syndrome [36]. Quinidine has been also effective in
patients with early repolarization syndrome [16]. These simila-
rities in responses to drugs between patients with Brugada
H. Watanabe, T. Minamino / Journal of Arrhythmia 29 (2013) 134–137 137syndrome and those with early repolarization syndrome suggest
the presence of common electrophysiological abnormalities that
have a critical role in the formation of arrhythmogenic substrates.
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